ArticleCancer biology & therapy2011

Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells.

Euphemia Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.